financetom
Business
financetom
/
Business
/
Visa, Mastercard reach revised swipe-fee settlement with merchants
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Visa, Mastercard reach revised swipe-fee settlement with merchants
Nov 10, 2025 6:18 AM

NEW YORK (Reuters) -Visa and Mastercard ( MA ) announced a revised settlement with merchants who accused the card networks of charging too much to accept their credit cards, after a judge rejected an earlier $30 billion accord as inadequate.

Monday's settlement would end 20 years of litigation where businesses accused Visa, Mastercard ( MA ) and banks of conspiring to violate U.S. antitrust laws, including through the card networks' collection of "swipe fees" to process transactions.

The accord, which requires court approval, calls for Visa and Mastercard ( MA ) to lower swipe fees, which are now typically 2% to 2.5%, by 0.1 percentage points for five years.

Merchants would be allowed to choose whether to accept U.S. cards in specific categories including commercial cards, premium consumer cards including many popular "rewards" cards, and standard consumer cards.

Standard consumer rates would be capped at 1.25% until the agreement expires. Merchants would also get more options to impose surcharges when people pay by credit card.

Also known as interchange fees, swipe fees totaled $111.2 billion in the United States in 2024, up from $100.8 billion in 2023 and quadruple the level in 2009, according to the National Retail Federation, the largest U.S. retail trade group.

Visa said the settlement provides merchants "of all sizes" with "meaningful relief, more flexibility and options to control how they accept payments from their customers."

Mastercard ( MA ) said smaller merchants in particular would benefit from more flexibility, lower costs and simpler rules, with businesses and consumers enjoying a "better payments experience."

Neither company admitted wrongdoing in agreeing to settle.

SOME MERCHANTS LIKELY TO OPPOSE SETTLEMENT

The settlement requires approval by U.S. District Judge Margo Brodie in Brooklyn, who rejected the $30 billion accord in June 2024.

That agreement would have lowered swipe fees by about 0.07 percentage points over five years, and also given merchants more room to impose surcharges.

But the judge said fees would remain elevated, and the $6 billion of annual savings for merchants was "paltry" relative to how much Visa and Mastercard ( MA ) could still charge.

She also faulted the accord for sticking merchants with the "Honor All Cards" rule requiring that they accept all Visa and Mastercard ( MA ) cards, or none.

Merchants have long also accused Visa and Mastercard ( MA ) of enforcing "anti-steering" rules that prevent businesses from directing customers toward cheaper means of payment.

Some merchants and trade groups will likely oppose the latest settlement, and some expressed opposition after The Wall Street Journal reported its outlines on Saturday.

The Merchants Payments Coalition said the fee reduction was "minuscule," and Visa and Mastercard ( MA ) would remain free to raise fees without restrictions once temporary cuts expired.

It also said merchants had "no choice" but to accept rewards cards, which account for 85% of all cards issued, and banks could still shift cards into different categories, effectively requiring merchants to accept all cards.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved